by B2i | Mar 1, 2024 | Press Releases
JUPITER, Fla. , March 01, 2024 — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein...
by B2i | Feb 28, 2024 | Press Releases
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on applying...
by B2i | Feb 21, 2024 | Press Releases
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 — Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial platforms for protein development and...
by B2i | Feb 13, 2024 | Press Releases
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 — Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a strategic...
by B2i | Feb 6, 2024 | Press Releases
JUPITER, Fla., Feb. 06, 2024 — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announced it has signed a fully funded evaluation...